Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interests of Steven M. Offer, Ph.D., focus on colorectal cancer initiation and progression. Dr. Offer's laboratory utilizes a diverse array of cutting-edge biochemical, molecular, cellular, genetic, pharmacological and clinical methods to identify and characterize the changes that occur within cells to drive tumorigenesis and cancer metastasis. The overall goal of Dr. Offer's research is to provide diagnostic tools to better individualize patient care, and also to identify targetable pathways for further anti-cancer drug development.
As the second leading cause of cancer-related deaths in the United States, colorectal cancer represents a significant public health concern. Dr. Offer's ultimate goal is to identify pathways that can be targeted by cancer therapeutics to better manage colorectal cancer and prevent tumor progression. Dr. Offer hopes that improved treatment options will not only improve treatment response rates but also improve the quality of life for cancer patients by minimizing adverse drug-related toxicities.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.